Patents by Inventor Michael John Owen

Michael John Owen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Diffusing device
    Patent number: 10479571
    Abstract: The present invention relates to a capsule (11) for diffusing a substance in a liquid within a receptacle (50). The capsule comprises an expandable element and, in a first state the capsule has a first width and in a second state the capsule has a second width. The width of the capsule in the second state is greater than that of the first state.
    Type: Grant
    Filed: March 1, 2016
    Date of Patent: November 19, 2019
    Inventors: David Robert Lanagan, Michael John Owen
  • A DIFFUSING DEVICE
    Publication number: 20180016069
    Abstract: The present invention relates to a capsule (11) for diffusing a substance in a liquid within a receptacle (50). The capsule comprises an expandable element and, in a first state the capsule has a first width and in a second state the capsule has a second width. The width of the capsule in the second state is greater than that of the first state.
    Type: Application
    Filed: March 1, 2016
    Publication date: January 18, 2018
    Inventors: David Robert Lanagan, Michael John Owen
  • DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE
    Publication number: 20150119264
    Abstract: The invention relates to novel variants that associate with Alzheimer's disease AD and their use in kits as a means for diagnosing AD; and also their use in nucleic acid molecules or cells/cell lines for identifying novel therapeutic, label of identification means.
    Type: Application
    Filed: April 14, 2014
    Publication date: April 30, 2015
    Applicant: University College Cardiff Consultants Limited
    Inventors: Julie Williams, Michael John Owen
  • DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE
    Publication number: 20130288906
    Abstract: The invention relates to novel variants that associate with Alzheimer's disease AD and their use in kits as a means for diagnosing AD; and also their use in nucleic acid molecules or cells/cell lines for identifying novel therapeutic, label of identification means.
    Type: Application
    Filed: May 3, 2013
    Publication date: October 31, 2013
    Inventors: Julie Williams, Michael John Owen
  • DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE
    Publication number: 20120122703
    Abstract: The invention relates to novel variants that associate with Alzheimer's disease AD and their use in kits as a means for diagnosing AD; and also their use in nucleic acid molecules or cells/cell lines for identifying novel therapeutic, label of identification means.
    Type: Application
    Filed: June 22, 2010
    Publication date: May 17, 2012
    Applicant: UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED
    Inventors: Julie Williams, Michael John Owen
  • METHOD FOR DETERMINING DNA COPY NUMBER BY COMPETITIVE PCR
    Publication number: 20110091900
    Abstract: The present invention relates to a method for determining the number of copies of DNA at a specific locus. The method comprises the step of co-amplifying a DNA sample of an exploratory species comprising the test locus with a competitor sample comprising an orthologous DNA sequence derived from a closely related species.
    Type: Application
    Filed: June 18, 2009
    Publication date: April 21, 2011
    Inventors: Nigel Melville Williams, Michael Conlon O'Donovan, Michael John Owen
  • Test and model for Alzheimer's disease
    Publication number: 20030165958
    Abstract: Model systems of Alzheimer's disease comprise a DNA sequence encoding an amyloid precursor protein (APP) isoform or fragment that has an amino acid substitution. The substituted amino acid may be other than valine at the amino acid position corresponding to amino acid residue position 717 of APP770. Methods of determining genetic predisposition to Alzheimer's disease are also disclosed.
    Type: Application
    Filed: February 3, 2003
    Publication date: September 4, 2003
    Applicant: Elan Pharmaceuticals
    Inventors: John Anthony Hardy, Marie-Christine Chartier-Harlin, Alison Mary Goate, Michael John Owen, Michael John Mullan
  • Transgenic mouse expressing an APP-FAD DNA sequence
    Patent number: 6300540
    Abstract: Model systems of Alzheimer's disease comprise a DNA sequence encoding an amyloid precursor protein (APP) isoform or fragment that has an amino acid substitution. The substituted amino acid may be other than valine at the amino acid position corresponding to amino acid residue position 717 of APP770. Methods of determining genetic predisposition to Alzheimer's disease are also disclosed.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: October 9, 2001
    Assignee: Elan Pharmaceuticals, Inc.
    Inventors: John Anthony Hardy, Marie-Christine Chartier-Harlin, Alison Mary Goate, Michael John Owen, Michael John Mullan
  • APP770 mutant in alzheimer's disease
    Patent number: 5877015
    Abstract: Model systems of Alzheimer's disease comprise a DNA sequence encoding an amyloid precursor protein (APP) isoform or fragment that has an amino acid substitution. The substituted amino acid may be other than valine at the amino acid position corresponding to amino acid residue position 717 of APP770. Methods of determining genetic predisposition to Alzheimer's disease are also disclosed.
    Type: Grant
    Filed: January 21, 1992
    Date of Patent: March 2, 1999
    Assignee: Imperial College of Science, Technology of Medicine
    Inventors: John Anthony Hardy, Marie-Christine Chartier-Harlin, Alison Mary Goate, Michael John Owen, Michael John Mullan